Centerpoint Advisory Group’s MAIA Biotechnology MAIA Stock Holding History

Centerpoint Advisory Group’s Portfolio MAIA Stock Details MAIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.7K	Hold	15,730	–	–	0.01%	117
2026 Q1	$22K	Hold	15,730	–	–	0.02%	108
2025 Q4	$24.1K	Hold	15,730	–	–	0.02%	107
2025 Q3	$24.2K	Hold	15,730	–	–	0.02%	108
2025 Q2	$28.3K	Buy	+15,730	New	+$28.2K	0.02%	100

Other funds holding MAIA

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

LCM

Lazari Capital Management Woodland Hills, California $325M AUM 32.83% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Centerpoint Advisory Group's MAIA Position: Q2 2026 in Review

Centerpoint Advisory Group held its MAIA Biotechnology (MAIA) position steady in Q2 2026 at 15,730 shares worth $22.7K. The position accounts for 0.01% of the portfolio, ranked #117.

Centerpoint Advisory Group first reported a position in MAIA in Q2 2025 and has held it in 5 quarters since. The position peaked at $28.3K in Q2 2025. 5 funds tracked by Wall St. Rank hold MAIA as of Q2 2026.

Centerpoint Advisory Group held 15,730 shares of MAIA Biotechnology worth $22.7K as of Q2 2026.
Centerpoint Advisory Group left its MAIA Biotechnology share count unchanged in Q2 2026.
MAIA Biotechnology made up 0.01% of Centerpoint Advisory Group's portfolio in Q2 2026, its #117 holding.
Centerpoint Advisory Group first reported a position in MAIA Biotechnology in Q2 2025 and has held it in 5 quarters since.
Centerpoint Advisory Group's MAIA Biotechnology position peaked at $28.3K in Q2 2025.
5 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2026.

Based on Centerpoint Advisory Group's 13F filing for Q2 2026, filed 29 Jul 2026.